Skip to main content

Table 2 Migraine Population - Drug Consumption

From: Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting

Variable, n (%)

Physician-assigned diagnosis patients

(n = 16,675)

Triptan-prescribed patients

(n = 14,091)

Overall

(n = 30,766)

Triptan

11,973 (71.8%)

14,091 (100.0%)

26,064 (84.7%)

Combination pain drug

6721 (40.3%)

5890 (41.8%)

12,611 (41.0%)

Opioid drug

5302 (31.8%)

4424 (31.4%)

9726 (31.6%)